StockClub

VPHIF

VPHIFValeo Pharma Inc.$ --
Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 07/31/2024FY2024 Q3
Revenue
13M CAD
YoY -10.5%
Operating Income
-3M CAD
YoY +6.1%
Net Income
-8M CAD
YoY -40.3%
EPS
-0.08CAD
YoY -20.1%

Revenue

CAD40.3M
FY2022 Q4CAD27.7M
CAD27.7M
Q4
FY2023 Q1CAD13.2M
CAD13.2M
Q1
FY2023 Q2CAD26.7M
CAD26.7M
Q2
FY2023 Q3CAD40.8M
CAD40.8M
Q3
FY2023 Q4CAD53.9M
CAD53.9M
Q4
FY2024 Q1CAD13.5M
CAD13.5M
Q1
FY2024 Q2CAD27.7M
CAD27.7M
Q2
FY2024 Q3CAD40.3M
CAD40.3M
Q3
Actual
CAD-533,000 (-1.3%)

Net Income

CAD-22.9M
FY2022 Q4CAD-25.7M
CAD-25.7M
Q4
FY2023 Q1CAD-6.2M
CAD-6.2M
Q1
FY2023 Q2CAD-12.7M
CAD-12.7M
Q2
FY2023 Q3CAD-18.6M
CAD-18.6M
Q3
FY2023 Q4CAD-27.8M
CAD-27.8M
Q4
FY2024 Q1CAD-6.9M
CAD-6.9M
Q1
FY2024 Q2CAD-14.7M
CAD-14.7M
Q2
FY2024 Q3CAD-22.9M
CAD-22.9M
Q3
Actual
CAD-4.3M (-23.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2018
Actual:CAD4.4M
FY2018
CAD4.4M
FY2019
Actual:CAD6.6M
FY2019
CAD6.6M
FY2020BEAT
Actual:CAD7.5M
Est:CAD6M
FY2020BEAT
CAD7.5M
FY2021BEAT
Actual:CAD13.6M
Est:CAD11M
FY2021BEAT
CAD13.6M
FY2022BEAT
Actual:CAD27.7M
Est:CAD20.1M
FY2022BEAT
CAD27.7M
FY2023BEAT
Actual:CAD53.9M
Est:CAD41.5M
FY2023BEAT
CAD53.9M

Analyst Estimates

Earnings Release History